Diabetes & Metabolism Journal

Review

Lifestyle and Behavioral Interventions
Optimizing Physical Activity Strategies for Older Adults with Diabetes: Hyeon-Jin Yu, Doyoun Hong, Kyuho Kim, Ji Hye Heo, Dong-Hyeok Cho, Yoshitaka Hashimoto, Jae-Seung Yun; Diabetes Metab J. 2025;49(6):1178-1197. Published online November 1, 2025; DOI: https://doi.org/10.4093/dmj.2025.0967

2,506 View
136 Download

Abstract PDF PubReader ePub: The increasing prevalence of diabetes among older adults has emerged as a major socioeconomic burden. This population is highly heterogeneous, ranging from functionally independent to severely impaired individuals, making it difficult to establish standardized recommendations. Physical activity (PA) is a cornerstone of diabetes management; however, current exercise guidelines do not adequately address the wide spectrum of functional capacities observed in older adults. For those with physical limitations, relatively simple activities such as walking, breaking up sedentary time, incorporating movement into daily routines, and aquatic exercise have been proposed, yet supporting evidence remains limited. This review summarizes the pathophysiologic mechanisms of metabolic and functional changes associated with aging and diabetes—including sarcopenia, altered body composition, and cardiovascular decline—and comprehensively discusses the benefits and precautions of various exercise modalities, tailored recommendations according to diabetes-related complications, and key clinical considerations. We further classified older adults with diabetes into three functional levels, individuals in good health, those with some comorbidities or mild disabilities, and those with high comorbidities and/or functional impairment, and proposed corresponding physical activity strategies for each level. Finally, we highlight practical and feasible approaches, including walking, interrupting sedentary behavior, daily functional movements, and aquatic exercise, to enhance clinical applicability for individuals with reduced physical capacity. These tailored, function-based strategies may help older adults with diabetes achieve safer, more effective, and sustainable improvements in glycemic control and overall health.

Corrigendum

Diabetes Fact Sheets in Korea 2024: Se Eun Park, Seung-Hyun Ko, Ji Yoon Kim, Kyuho Kim, Joon Ho Moon, Nam Hoon Kim, Kyung Do Han, Sung Hee Choi, Bong Soo Cha; Diabetes Metab J. 2025;49(3):524-524. Published online May 1, 2025; DOI: https://doi.org/10.4093/dmj.2024.0818.c1; Corrects: Diabetes Metab J 2025;49(1):24

2,604 View
63 Download
5 Web of Science
6 Crossref

PDF PubReader ePub

Citations

Citations to this article as recorded by

Impact of smart watch mobile application on the risk treatment of type 2 diabetes mellitus (iSMART-DM)
Min Kyoung Jang, Yun Kyung Cho, Jung Yoon Moon, Se Hee Min, Ju Hee Hwang, Chang Hee Jung
Primary Care Diabetes.2026; 20(1): 47. CrossRef
Impact of Hospitalist-Led Care on Glycemic Control Among Hospitalized Adults with Diabetes in Korea
Soohyun Lee, Jaewoong Kim, Areum Shin, Sunhee Jo, Chul Sik Kim, Taeyoung Kyong
Journal of Clinical Medicine.2026; 15(2): 406. CrossRef
Association between extracellular-to-intracellular water ratio and type 2 diabetes mellitus in Korean males aged 19-80 years: analysis of KNHANES 2022-2023
Seung-Hee Lee, Seo-Jeong Heo, Jonghoon Park
Physical Activity and Nutrition.2025; 29(2): 77. CrossRef
Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control
Seung Hee Lee, Hyeon Young Park, Ji Ho Yun, Eun Kyoung Do
Frontiers in Endocrinology.2025;[Epub] CrossRef
Clinically Practical and Affordable Lifestyle Modification to Prevent Diabetes Mellitus in Real Practice
Inji Lee, Minji Kang, Ji Hye Choi, Hyunjung Lim, Suk Chon
Diabetes & Metabolism Journal.2025; 49(5): 951. CrossRef
Real‐World Evidence of Long‐Term Dulaglutide Use: Sustained Glycemic and Weight Improvements Beyond Three Years
Hwi Seung Kim, Myung Jin Kim, Hee Sung Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee
Clinical Endocrinology.2025;[Epub] CrossRef

Original Articles

Guideline/Statement/Fact Sheet
Older Adults with Diabetes in Korea: Latest Clinical and Epidemiologic Trends: Kyuho Kim, Bongseong Kim, Kyuna Lee, Yu-Bae Ahn, Seung-Hyun Ko, Sung Hee Choi, Kyungdo Han, Jae-Seung Yun, on Behalf of the Committee of Public Relation of the Korean Diabetes Association; Diabetes Metab J. 2025;49(2):183-193. Published online March 1, 2025; DOI: https://doi.org/10.4093/dmj.2024.0836

6,978 View
343 Download
3 Web of Science
5 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Diabetes in older adults is becoming a significant public burden to South Korea. However, a comprehensive understanding of epidemiologic trends and the detailed clinical characteristics of older adults with diabetes is lacking. Therefore, we evaluated epidemiologic trends and the metabolic and lifestyle characteristics of diabetes in Korean older adults.
Methods
We analyzed data from the Korea National Health and Nutrition Examination Survey to assess diabetes prevalence according to diabetes duration and lifestyle behaviors. In addition, we drew upon the National Health Information Database of the National Health Insurance System to assess physical activity levels, antidiabetic medication use, polypharmacy, medication adherence, and major comorbidities.
Results
The absolute number of newly diagnosed cases of diabetes among older adults doubled over the past decade. Management rates of metabolic indicators were higher in older adults with diabetes compared to those without diabetes. The proportion of older adults with diabetes meeting the minimum recommended physical activity increased over the years. Compared to 10 years before, the use of dipeptidyl peptidase-4 inhibitor or sodium-glucose cotransporter-2 inhibitor had increased, as had comorbidities such as dyslipidemia, dementia, cancer, heart failure, atrial fibrillation, and chronic kidney disease. Initial medication adherence was significantly lower in those with end-stage kidney disease or dementia, insulin use, high-risk alcohol use, and living alone. Continuing insulin use 1 year after diagnosis of diabetes was significantly higher in those who initiated insulin therapy at diagnosis, had retinopathy, were on triple antidiabetic medications, and had a history of cancer.
Conclusion
Comprehensive management of metabolic indicators and physical activity is essential for older adults with diabetes. Improvements in prescribing guidelines, personalized management of age-related comorbidities, and individualized approaches that consider the heterogeneous nature of older adults with diabetes are desirable. Further research, such as high-quality cohort and intervention studies specific to older adults, is needed to establish evidence-based management for older adults with diabetes.

Citations

Citations to this article as recorded by

Rising mortality from electrolyte and acid–base imbalances in the United States (1999–2020): a joinpoint regression analysis of national trends and disparities
Zaima Afzaal, Asma Chaudhary, Inshal Uddin Khattak, Saba Aliha, Asad Khan, Anas M Din Bashir, Hameer Ali, Amnah Khan, Aizaz Anwar Khalid, Wania Khan, Touqeer Rehman, Maryam Atif, Areen Zia, Mazia Mahnoor, Rumman Javed, Saad Ahmed Waqas, Raheel Ahmed, Soma
Annals of Medicine & Surgery.2026; 88(1): 362. CrossRef
Exploring the Lack of Physical Activity among Adolescents Worldwide
Dalmacito A. Cordero Jr.
Diabetes & Metabolism Journal.2025; 49(3): 513. CrossRef
Clinical Considerations for Safe Use of SGLT2 Inhibitors
Jae-Seung Yun, Eonju Jeon
The Journal of Korean Diabetes.2025; 26(2): 60. CrossRef
A Position Statement on Management of Diabetes in Older Adults
Jae-Seung Yun, Jin Hwa Kim, Sung Hoon Yu, Kyung Ae Lee, Hye Seung Jung, Ji Hye Heo, Jong-Ha Baek, Dong Hyeok Cho
The Journal of Korean Diabetes.2025; 26(3): 141. CrossRef
Optimizing Physical Activity Strategies for Older Adults with Diabetes
Hyeon-Jin Yu, Doyoun Hong, Kyuho Kim, Ji Hye Heo, Dong-Hyeok Cho, Yoshitaka Hashimoto, Jae-Seung Yun
Diabetes & Metabolism Journal.2025; 49(6): 1178. CrossRef

Metabolic Risk/Epidemiology
The Impact of Obesity on the Association between Parity and Risk of Type 2 Diabetes Mellitus: Yuki Gen, Kyuho Kim, Joonyub Lee, Junyoung Jung, Sang-Hyuk Jung, Hong-Hee Won, Dokyoon Kim, Yun-Sung Jo, Yu-Bae Ahn, Seung-Hyun Ko, Jae-Seung Yun; Diabetes Metab J. 2025;49(4):837-847. Published online February 14, 2025; DOI: https://doi.org/10.4093/dmj.2024.0536

5,715 View
185 Download
1 Web of Science
2 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Most studies focus solely on the relationship between parity and type 2 diabetes mellitus (T2DM) risk, providing limited insights into other contributing or protective factors. This study aims to explore the complex relationship between parity and T2DM risk, considering additional factors such as obesity, race, and body composition.
Methods
This prospective cohort study used data from 242,159 women aged 40 to 69 from the UK Biobank, none of whom had T2DM at baseline. Multivariable Cox proportional hazard models were applied to assess the association between parity and T2DM. Subgroup analyses were performed based on body mass index (BMI), waist circumference (WC), and race.
Results
The hazard ratio for T2DM per additional child was 1.16 (95% confidence interval, 1.13 to 1.16). Subgroup analysis revealed that Asian women and those with obesity or abdominal obesity had a higher risk of T2DM associated with multiparity. No increased risk was observed in women with normal BMI or WC. Mediation analysis showed that WC and BMI significantly mediated the parity-T2DM relationship, accounting for 49% and 38% of the effect, respectively.
Conclusion
There is a clear positive association between multiparity and T2DM risk, particularly in Asian women and those with obesity. Maintaining normal BMI and WC appears to mitigate this risk, highlighting the importance of weight management for women at higher parity levels. These findings offer crucial insights for public health interventions aimed at reducing T2DM risk among women.

Citations

Citations to this article as recorded by

Multiparity as a key variable in metabolism and pregnancy research
Tracy K Her, V Pszczolkowski, Grace Chung, Laura A Woollett, Emilyn U Alejandro
Current Opinion in Physiology.2026; 47: 100926. CrossRef
Baseline and longitudinal changes of body roundness index and incident type 2 diabetes: evidence from the UK Biobank cohort
Xuanli Zhao, Fangyuan Jing, Yanan Ren, Jing Zhu, Xinzhe Jing, Meiqun Lv, Ke Huang, Jing Guo, Jiayu Li, Xiaohui Sun, Yingying Mao, Ding Ye
BMJ Open Diabetes Research & Care.2025; 13(5): e005339. CrossRef

Guideline/Statement/Fact Sheet
Diabetes Fact Sheets in Korea 2024: Se Eun Park, Seung-Hyun Ko, Ji Yoon Kim, Kyuho Kim, Joon Ho Moon, Nam Hoon Kim, Kyung Do Han, Sung Hee Choi, Bong Soo Cha; Diabetes Metab J. 2025;49(1):24-33. Published online January 1, 2025; DOI: https://doi.org/10.4093/dmj.2024.0818; Correction in: Diabetes Metab J 2025;49(3):524

24,855 View
1,528 Download
31 Web of Science
49 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
This study aimed to investigate the prevalence, management, and comorbidities of diabetes mellitus among Korean adults.
Methods
Data from the Korea National Health and Nutrition Examination Survey (2019–2022) were analyzed to assess the prevalence, treatment, risk factors, and comorbidities of diabetes. Comparisons between young and older adults with diabetes were emphasized.
Results
Among Korean adults aged ≥30 years, the prevalence of diabetes is 15.5% during 2021–2022. Of these, 74.7% were aware of their condition, 70.9% received antidiabetic treatment, and only 32.4% achieved glycosylated hemoglobin (HbA1c) <6.5%. Moreover, 15.9% met the integrated management targets, which included HbA1c <6.5%, blood pressure <140/85 mm Hg, and low-density lipoprotein cholesterol <100 mg/dL. In young adults aged 19 to 39 years, the prevalence of diabetes was 2.2%. Among them, 43.3% were aware of their condition, 34.6% received treatment, and 29.6% achieved HbA1c <6.5%. Obesity affected 87.1%, and 26.9% had both hypertension and hypercholesterolemia. Among adults aged ≥65 years, the prevalence of diabetes was 29.3%, with awareness, treatment, and control rates of 78.8%, 75.7%, and 31.2%, respectively. Integrated management targets (HbA1c <7.5%, hypertension, and lipids) were achieved by 40.1%.
Conclusion
Diabetes mellitus remains highly prevalent among Korean adults, with significant gaps in integrated glycemic, blood pressure, and lipid control. Older adults with diabetes show higher awareness and treatment rates but limited integrated management outcomes. Young adults with diabetes bear a significant burden of obesity and comorbidities, alongside low awareness and treatment rates. Therefore, early intervention programs, education, and strategies tailored to younger populations are urgently required.

Citations

Citations to this article as recorded by

Glucose tolerance and mortality across 24 cancer types and stages: A K‐CURE Nationwide registry study
Kyung‐Hun Sung, Jin Yu, Seyoon Kim, Mee Kyoung Kim, Yong‐Moon Mark Park, Kyungdo Han, Seung‐Hwan Lee
Diabetes, Obesity and Metabolism.2026; 28(3): 2051. CrossRef
Identification of antidiabetic leads using in-silico screening, molecular dynamics simulation, and biological evaluation using cell viability, anti-adipogenesis, glucose uptake, and peroxisome proliferator activated receptor-γ in-vitro assay
Virendra Nath, K. Prem Ananth, Titpawan Nakpheng, Kanyanat Kaewiad, Juthanat Kaeobamrung, Teerapol Srichana
Journal of Computer-Aided Molecular Design.2026;[Epub] CrossRef
Reproductive Lifespan and Reproductive Factors in Relation to Dementia Risk in Postmenopausal Women With Type 2 Diabetes
Jin Yu, Jae-Hyoung Cho, Kyungdo Han, Yong-Moon Mark Park, Seung-Hwan Lee
Diabetes Care.2026; 49(2): 292. CrossRef
Causal analysis of traditional and environmental risk factors for long-term development of type 2 diabetes using a conditional survival Bayesian network: evidence from the Korean Genome and Epidemiology Study
Ji Young Choi, Man-Suk Oh
BMC Public Health.2026;[Epub] CrossRef
Tracking three decades of type 1 diabetes‐related chronic kidney disease in East Asia: Burden, age–sex patterns, and quality of care index
Qiongfang Zhang, Huan Wang, Mei Sun, Yi Wu, Pan Xie
Journal of Diabetes Investigation.2026;[Epub] CrossRef
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial
Seung‐Hwan Lee, Kyung Ah Han, Eun‐Gyoung Hong, Jun Goo Kang, Choon Hee Chung, Jong Chul Won, Eon Ju Jeon, Jung‐Hwan Cho, Ho Chan Cho, Sin Gon Kim, Eun Seok Kang, So Hun Kim, Hae Jin Kim, In‐Kyung Jeong, Sung Wan Chun, Young Min Cho
Diabetes, Obesity and Metabolism.2026; 28(3): 2027. CrossRef
Diabetes in Korean Adults: Prevalence, Management, and Comorbidities
Sung Hoon Yu
Diabetes & Metabolism Journal.2025; 49(1): 22. CrossRef
Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study
Kyoung Hwa Ha, Won Kim, Dong Han Kim, Dae Jung Kim
Journal of Diabetes and its Complications.2025; 39(5): 108983. CrossRef
A Machine Learning-Based Prediction Model for Diabetic Kidney Disease in Korean Patients with Type 2 Diabetes Mellitus
Kyung Ae Lee, Jong Seung Kim, Yu Ji Kim, In Sun Goak, Heung Yong Jin, Seungyong Park, Hyejin Kang, Tae Sun Park
Journal of Clinical Medicine.2025; 14(6): 2065. CrossRef
Glucagon-Like Peptide-1 Receptor Agonists: What’s the Optimizing Policies for Obesity-Related Metabolic Diseases?
Tae Sun Park
Diabetes & Metabolism Journal.2025; 49(2): 169. CrossRef
Older Adults with Diabetes in Korea: Latest Clinical and Epidemiologic Trends
Kyuho Kim, Bongseong Kim, Kyuna Lee, Yu-Bae Ahn, Seung-Hyun Ko, Sung Hee Choi, Kyungdo Han, Jae-Seung Yun
Diabetes & Metabolism Journal.2025; 49(2): 183. CrossRef
How Do We Diagnose Diabetes in Primary Care?
Hyeong Jin Kim
The Journal of Korean Diabetes.2025; 26(1): 10. CrossRef
Prevention and Management of Prediabetes
Jae Min Lee
The Journal of Korean Diabetes.2025; 26(1): 18. CrossRef
Feasibility of a Structured Calorie-Restricted Dietary Intervention in Korean Adults with Early Type 2 Diabetes and Obesity: A Pilot Study
Su-Jeong Park, Mee Kyung Kim, Jinyoung Kim, Ji-Yeon Choi, YoonJu Song, Hyuk-Sang Kwon
Nutrients.2025; 17(9): 1530. CrossRef
Prevalence and Current Status of Cardiometabolic Risk Factors in Korean Adults Based on Fact Sheets 2024
Eun-Jung Rhee
Endocrinology and Metabolism.2025; 40(2): 174. CrossRef
Diabetes advocacy in the Asia–Pacific region
Noriko Kodani, Asuka Kato, Moon‐Kyu Lee, Ronald Ching Wan Ma, Anita Sabidi, Renza Scibilia, Zhiguang Zhou, Alicia Jenkins
Journal of Diabetes Investigation.2025; 16(7): 1191. CrossRef
Fatty liver index and risk of type 2 diabetes of adults with normoglycemia: Insights into insulin sensitivity and beta-cell function
Ji Hyun Bae, Min Jin Lee, Su Hyun Kim, Joo Yeon Kim, Ah Reum Khang, Yang Ho Kang, Dongwon Yi, Guoying Wang
PLOS One.2025; 20(6): e0327058. CrossRef
Initial Evaluation of Patients with Diabetes Mellitus according to Clinical Guidelines
Dughyun Choi
The Journal of Korean Diabetes.2025; 26(2): 69. CrossRef
Overlooked Dimensions of Diabetes: Suicide Risk and Need for Holistic Care
Eu Jeong Ku
The Journal of Korean Diabetes.2025; 26(2): 55. CrossRef
Sex-Specific Associations of Glycemic Status and Smoking with Bladder Cancer Risk: A Nationwide Cohort Study
Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Jay J. Shen
Cancers.2025; 17(13): 2262. CrossRef
Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality
Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
Cardiovascular Diabetology.2025;[Epub] CrossRef
Case Report on the Improvement of Uncontrolled Blood Glucose with Shihogayonggolmoryo-tang, Yeonggyechulgam-tang, and Korean Medicine Complex Therapy
Nahyun Cho, Chul-woo Ahn, Hyungsun Jun, Hyun-jong Jung, Dasol Park, Jungtae Leem
The Journal of Internal Korean Medicine.2025; 46(3): 511. CrossRef
Glycemic Stability Maintained with Yeongyopaedok-san and Insampaedok-san in Type 2 Diabetes: A Retrospective Observational Study
Yeon-Joo Yoo, Mee-Ryoung Song, Woo-nyoung Jung, Min-seong Lee, Young-min Ahn, Se-young Ahn, Byung-cheol Lee
The Journal of Internal Korean Medicine.2025; 46(3): 454. CrossRef
The distribution of artificial intelligence–derived retinal cardiovascular risk scores and conventional risk factors in two Korean health screening cohorts: a descriptive study
Jungkyung Cho, Jaewon Seo, Junseok Park, Dongjin Nam, Tae Hyun Park, Sahil Thakur, Tyler Hyungtaek Rim, Beom-hee Choi, Miso Jang
Cardiovascular Prevention and Pharmacotherapy.2025; 7(3): 73. CrossRef
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP‐4 inhibitors: A multicentre, phase 4 randomized controlled trial
Yun Kyung Cho, Jae‐Hyoung Cho, Sang‐Mo Hong, Jung Hwan Park, Byung‐Wan Lee, Jee Hee Yoo, Jae Hyeon Kim, Sung Wan Chun, You‐Cheol Hwang, Kee‐Ho Song, Woo Je Lee
Diabetes, Obesity and Metabolism.2025; 27(11): 6375. CrossRef
Effects of Pilates exercise on glycated hemoglobin and fasting blood sugar in type 2 diabetes: a systematic review and meta-analysis
Se-Na Yu, Hee-Jin Moon, Myung-Haeng Hur
Journal of Korean Biological Nursing Science.2025; 27(3): 317. CrossRef
Non HIV-Associated Buffalo Hump as a Clinical Marker of Metabolic Disease
Nae-Ho Lee, Beom Jin Lim, Jin Yong Shin, Yoon Kyu Chung, Si-Gyun Roh
Journal of Clinical Medicine.2025; 14(17): 5997. CrossRef
Association between Handgrip Strength and Depression and Anxiety in Korean Adults: Analysis of the 2014–2023 Korea National Health and Nutrition Examination Survey
Jaewoo Kim, Yeon Soo Kim, Younghwan Choi
The Korean Journal of Sports Medicine.2025; 43(3): 163. CrossRef
Is the next STEP on the BPROAD to intensive blood pressure lowering for all type 2 diabetic patients?: consensus statements from the Korean Society of Hypertension
Eun Mi Lee, In-Jeong Cho, Hae Jin Kim, Dae-Hee Kim, Hae-Young Lee, Sungha Park, Sang-Hyun Ihm
Clinical Hypertension.2025;[Epub] CrossRef
2025 Clinical Practice Guidelines for Diabetes: Cardiovascular Risk Management
Hae Jin Kim
The Journal of Korean Diabetes.2025; 26(3): 164. CrossRef
Risk of Sarcopenic Obesity Across Menopausal Transition Stages in Middle-Aged Korean Women
Yoosun Cho, Yoonyoung Jang, Jae Ho Park, Yoosoo Chang, Seungho Ryu
Nutrients.2025; 17(20): 3238. CrossRef
Non-Invasive Glucose Measurement Using Electric Field and Temperature Sensor
Jinwoo Song, Inju Jung, Jooran Yang, Hyungpyo Kim
JOURNAL OF SENSOR SCIENCE AND TECHNOLOGY.2025; 34(5): 549. CrossRef
Social Stigma in People with Diabetes
Soo Mi Jang
The Journal of Korean Diabetes.2025; 26(3): 188. CrossRef
Psychometric Properties of the Short-Form Revised Lifestyle Evaluation Scale for Metabolic Syndrome–Korean
Shinae Seo, Chun-Ja Kim, Se-Won Kang, Dae Jung Kim, Elizabeth A. Schlenk
The Science of Diabetes Self-Management and Care.2025; 51(6): 578. CrossRef
Cost-Effectiveness Analysis of Real-Time Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in People With Type 2 Diabetes Treated With Non-Intensive Insulin Therapy in South Korea
Ji Yoon Kim, Sabrina Ilham, Hamza Alshannaq, Richard F. Pollock, Martin Field, Gregory J. Norman, Sang-Man Jin, Jae Hyeon Kim
Journal of Diabetes Science and Technology.2025;[Epub] CrossRef
Generative AI Chatbot for Diabetes Management: Formative 2-Part Qualitative Study Using DTalksBot Involving Patients and Clinicians
Soyun Jeon, Seolhee Lee, Esther Hehsun Kim, Jinsu Eun, Kwangwon Lee, Hajin Lim, Joonhwan Lee
JMIR Formative Research.2025; 9: e72553. CrossRef
Cumulative burdens as determinants of diabetes self-management: examining disparities across income levels
Eunji Nam, Soo Mi Jang
Diabetes Research and Clinical Practice.2025; 230: 112986. CrossRef
Beta-Cell Function, Insulin Sensitivity, and Metabolic Characteristics in Young-Onset Type 2 Diabetes Mellitus: Findings from Anam Diabetes Observational Study
Ji Yoon Kim, Jiyoon Lee, Sin Gon Kim, Nam Hoon Kim
Diabetes & Metabolism Journal.2025; 49(6): 1287. CrossRef
Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes
Jong Han Choi, Shinae Kang, Soo-Kyung Kim, Won Jun Kim, Ji Min Kim, Jaehyun Bae, Jae-Seung Yun, Eonju Jeon, Young-Eun Kim, Jae Hyun Bae, Hun Jee Choe, Young Min Cho, Seung-Hyun Ko, Sang Yong Kim, Hae Jin Kim, You-Cheol Hwang, Min Kyong Moon, Suk Chon, Seo
Diabetes & Metabolism Journal.2025; 49(6): 1155. CrossRef
Molecular impact of single nucleotide polymorphisms in GIPR gene among type 2 diabetes mellitus patients in the Saudi population
Zeina S. Alkudmani, Yazeed Alshuweishi, Sarah F. Alsobaie, Imran Ali Khan
Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Longitudinal Association Between Menopausal Transition and Obstructive Sleep Apnea with Effect Modification by Salt Intake: A Prospective Cohort Study
Sujeong Shin, Yoonyoung Jang, Yoosoo Chang, Seungho Ryu
Nutrients.2025; 17(22): 3612. CrossRef
Effects of a health coaching program based on Cox’s interaction model in older adults with diabetes mellitus in Korea: a quasi-experimental study
Hye Seung Kang
Journal of Korean Biological Nursing Science.2025; 27(4): 607. CrossRef
National trends in the prevalence of hypertension and diabetes stratified by sleep duration in South Korea, 2009–2022: A nationwide cross-sectional study: Trends and association of sleep duration in hypertension and diabetes
Jinyoung Jeong, Hyunjee Kim, Jaeyu Park, Hyeon Jin Kim, Hyesu Jo, Sooji Lee, Kyeongmin Lee, Seoyoung Park, Yesol Yim, Ho Geol Woo, Yejun Son, Soeun Kim, Sang Youl Rhee, Dong Keon Yon
Medicine.2025; 104(47): e46042. CrossRef
Classification of self-care patterns in Korean adults with prediabetes using unsupervised machine learning: a secondary data analysis
Mi-Kyoung Cho, Myoung-Lyun Heo
Journal of Korean Biological Nursing Science.2025; 27(4): 586. CrossRef
Clinical Considerations in Managing Obesity and Obesity-Related Comorbidities
Hyojin Park, Sun Hyun Kim
Korean Journal of Family Practice.2025; 15(4): 186. CrossRef
National trends in the unmet healthcare needs among patients with hypertension or type 2 diabetes mellitus in Korea from 2009 to 2023
Yeona Jo, Seoyoung Park, Soeun Kim, Yejun Son, Jaeyu Park, Hanseul Cho, Louis Jacob, Damiano Pizzol, Guillermo F. López Sánchez, Lee Smith, Selin Woo, Dong Keon Yon
Scientific Reports.2025;[Epub] CrossRef
Digital Healthcare and Diabetic Retinopathy: Patient Experience Innovation and Support for Diabetes Care
Sang Jun Park
The Journal of Korean Diabetes.2025; 26(4): 208. CrossRef
Effects of Diabetes Diagnosis Status and Self-Management Factors on Fundus Examination Participation
Dae-Jong Kim
Journal of Korean Ophthalmic Optics Society.2025; 30(4): 403. CrossRef
Review of Research Trends in Traditional Korean Medicine for Diabetes Mellitus: Scoping Review Focusing on Recently Published Domestic Studies
Ji-young Son, Su-yong Shin, Jung-sang Kim, Min-whee Kang, Dong-hun Lee, Jun-ho Kim, Chung-hee Kim, Byung-soo Kang, Ga-jin Han, Min-woo Bang
The Journal of Internal Korean Medicine.2025; 46(6): 1257. CrossRef

Review

Others
Holistic and Personalized Strategies for Managing in Elderly Type 2 Diabetes Patients: Jae-Seung Yun, Kyuho Kim, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko; Diabetes Metab J. 2024;48(4):531-545. Published online July 26, 2024; DOI: https://doi.org/10.4093/dmj.2024.0310

23,193 View
748 Download
7 Web of Science
10 Crossref

Abstract PDF PubReader ePub

Due to increased life expectancy and lifestyle changes, the prevalence of diabetes among the elderly in Korea is continuously rising, as is the associated public health burden. Diabetes management in elderly patients is complicated by age-related physiological changes, sarcopenia characterized by loss of muscle mass and function, comorbidities, and varying levels of functional, cognitive, and mobility abilities that lead to frailty. Moreover, elderly patients with diabetes frequently face multiple chronic conditions that elevate their risk of cardiovascular diseases, cancer, and mortality; they are also prone to complications such as hyperglycemic hyperosmolar state, diabetic ketoacidosis, and severe hypoglycemia. This review examines the characteristics of and management approaches for diabetes in the elderly, and advocates for a comprehensive yet personalized strategy.

Citations

Citations to this article as recorded by

Reproductive Lifespan and Reproductive Factors in Relation to Dementia Risk in Postmenopausal Women With Type 2 Diabetes
Jin Yu, Jae-Hyoung Cho, Kyungdo Han, Yong-Moon Mark Park, Seung-Hwan Lee
Diabetes Care.2026; 49(2): 292. CrossRef
Knowledge, perceptions and attitudes toward diabetes care in oncology: a pilot survey across specialties (DiaLog Study)
Guler Nur Tekustun, Besra Hazal Yesil-Gurel, Sait Kitapli, Ali Alkan, Ozgur Tanriverdi
Endocrine.2026;[Epub] CrossRef
Diabetes Fact Sheets in Korea 2024
Se Eun Park, Seung-Hyun Ko, Ji Yoon Kim, Kyuho Kim, Joon Ho Moon, Nam Hoon Kim, Kyung Do Han, Sung Hee Choi, Bong Soo Cha
Diabetes & Metabolism Journal.2025; 49(1): 24. CrossRef
The effect of multidisciplinary team and experience-based co-design on the care of older adult patients with type 2 diabetes: A randomized controlled trial
Yujun Zhuang, Hongjiang Ye, Xiaoyan Yang, Lifang Zheng, Zhizhen Chen, Jianjia Jiang, Lunpan Mou, Pingping Li, Jiawei Qin, Yaduan Dai, Yanling Mao
Diabetes Research and Clinical Practice.2025; 221: 112028. CrossRef
Older Adults with Diabetes in Korea: Latest Clinical and Epidemiologic Trends
Kyuho Kim, Bongseong Kim, Kyuna Lee, Yu-Bae Ahn, Seung-Hyun Ko, Sung Hee Choi, Kyungdo Han, Jae-Seung Yun
Diabetes & Metabolism Journal.2025; 49(2): 183. CrossRef
Preventing End-Stage Kidney Disease in Older Adults with Type 2 Diabetes Mellitus: Optimal Blood Pressure Targets
Jae-Seung Yun, Seung-Hyun Ko
Diabetes & Metabolism Journal.2025; 49(6): 1198. CrossRef
Optimizing Physical Activity Strategies for Older Adults with Diabetes
Hyeon-Jin Yu, Doyoun Hong, Kyuho Kim, Ji Hye Heo, Dong-Hyeok Cho, Yoshitaka Hashimoto, Jae-Seung Yun
Diabetes & Metabolism Journal.2025; 49(6): 1178. CrossRef
The Relationship Between Diabetes Burden and Frailty in Older Adults with Diabetes
Tuğçe Türten Kaymaz, Ezgi Mutluay Yayla, Hanife Efsane Demiröz
Global Nursing Insights.2025; 12(3): 257. CrossRef
The burden of atherosclerotic cardiovascular disease in an aging population: A comprehensive review of risk factors, risk assessment, and prevention
Witold Żurański, Mariusz Gąsior, Bartosz Hudzik
Annales Academiae Medicae Silesiensis.2025; 79: 404. CrossRef
MODERN TECHNOLOGIES IN MONITORING AND TREATING TYPE 2 DIABETES IN THE ELDERLY
Elżbieta Stec-Sawina, Agnieszka Sawina, Sara Rakotoarison, Jakub Fiegler-Rudol, Karolina Lau, Janusz Kasperczyk
Health Problems of Civilization.2025;[Epub] CrossRef

Original Articles

Guideline/Fact Sheet
Diabetes Mellitus in the Elderly Adults in Korea: Based on Data from the Korea National Health and Nutrition Examination Survey 2019 to 2020: Seung-Hyun Ko, Kyung Do Han, Yong-Moon Park, Jae-Seung Yun, Kyuho Kim, Jae-Hyun Bae, Hyuk-Sang Kwon, Nan-Hee Kim; Diabetes Metab J. 2023;47(5):643-652. Published online August 7, 2023; DOI: https://doi.org/10.4093/dmj.2023.0041

11,028 View
380 Download
21 Web of Science
25 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
We evaluated the prevalence and management of diabetes mellitus (DM) in elderly Korean patients based on data from the Korea National Health and Nutrition Examination Survey (KNHANES).
Methods
A total of 3,068 adults aged 65 years and older (19.8% of total population) were analyzed using KNHANES from 2019 to 2020. Prevalence, awareness, treatment, and control rates, and comorbidities were analyzed. Lifestyle behaviors and energy intake were also measured.
Results
The prevalence of DM and prediabetes was 29.6% and 50.5%, respectively. The awareness, treatment and control rates were 76.4%, 73.3%, and 28.3%, respectively. The control rate was 77.0% if A1C <7.5% criteria was used. The mean A1C value of individuals with known DM was 7.1%, and 14.5% of the known DM patients had A1C ≥8.0%. Abdominal obesity, hypertension, and hypercholesterolemia were combined with DM in 63.9%, 71.7%, and 70.7%, respectively, and the rate of integrated management was 36.0% (A1C <7.5% criteria). A total of 40.1% of those with DM walked regularly. The percentage of energy intake from carbohydrates was higher in those with DM than in those without DM (P=0.044), while those of fat (P=0.003) and protein (P=0.025) were lower in those with DM than in those without DM in women.
Conclusion
In 2019 to 2020, three of 10 adults aged 65 years and older in Korea had DM, and approximately 70% of them had comorbidities. A strategy for more individualized comprehensive care for the elderly patients with DM is urgently needed.

Citations

Citations to this article as recorded by

Reply–Letter to the editor: “Reappraising diabetes prevalence and multimorbidity adjustment in geriatric nutrition research”
Pinar Soysal, Müberra Tanrıverdi, Cihan Heybeli
Clinical Nutrition ESPEN.2026; 72: 102805. CrossRef
Combined association of socioeconomic status and type 2 diabetes with influenza vaccination in older adults: A cross-sectional analysis of the Korea National Health and Examination Survey (2019–2022)
Sunghak Kim, Kyuwoong Kim, Benjamin Jun Jie Seng
PLOS One.2026; 21(2): e0341831. CrossRef
Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
Kyoung Hwa Ha, Soyoung Shin, EunJi Na, Dae Jung Kim
Journal of Diabetes Investigation.2025; 16(2): 215. CrossRef
Impact of diabetes duration and hyperglycemia on the progression of diabetic kidney disease: Insights from the KNHANES 2019-2021
Chang Seong Kim, Sang Heon Suh, Hong Sang Choi, Eun Hui Bae, Seong Kwon Ma, Bongseong Kim, Kyung-Do Han, Soo Wan Kim
World Journal of Diabetes.2025;[Epub] CrossRef
Older Adults with Diabetes in Korea: Latest Clinical and Epidemiologic Trends
Kyuho Kim, Bongseong Kim, Kyuna Lee, Yu-Bae Ahn, Seung-Hyun Ko, Sung Hee Choi, Kyungdo Han, Jae-Seung Yun
Diabetes & Metabolism Journal.2025; 49(2): 183. CrossRef
Exploring Middle Ear Pathologies in Adults with Diabetes Mellitus: A Scoping Review of Available Evidence and Research Gaps
Ben Sebothoma, Katijah Khoza-Shangase, Gift Khumalo, Boitumelo Mokwena
International Journal of Environmental Research and Public Health.2025; 22(4): 503. CrossRef
Possible association between metabolic dysfunction-associated steatotic liver disease predictors and hand grip strength
Suyeon Lee, Jong-Koo Kim, Taesic Lee
Scientific Reports.2025;[Epub] CrossRef
Association between mental disorders and suicide risk among people with type 2 diabetes
Han-Sang Baek, Kyu-Na Lee, Dong Woo Kang, Jae-Seung Yun, Hyuk-Sang Kwon, Kyungdo Han, Seung-Hwan Lee
Journal of Affective Disorders.2025;[Epub] CrossRef
Prevalence of Mortality and Vascular Complications in Older Patients with Diabetes in Korea
Kwang Joon Kim, Jeongmin Lee, Yang Sun Park, Yong-ho Lee, Kyeong Hye Park, Hee-Won Jung, Chang Oh Kim, Man Young Park, Hun-Sung Kim, Bong-Soo Cha
Endocrinology and Metabolism.2025; 40(3): 448. CrossRef
Clinical Efficacy of Integrated Hypertension-Hyperglycemia-Hyperlipidemia Management in Elderly Diabetic Patients: A Community-Based Intervention Study
三敏周
Advances in Clinical Medicine.2025; 15(06): 1452. CrossRef
2024 Cardio-cerebrovascular disease fact sheet in Korea
Kyungdo Han, Jin-Hyung Jung, Sang-Suk Choi, Seung-Hyun Ko
Cardiovascular Prevention and Pharmacotherapy.2025; 7(3): 85. CrossRef
Profil Morbiditas Pasien Lansia Di Kota Bandar Lampung : Studi Cross Sectional Multicenter
Nurul Irna Windari, Dirga Dirga, Rizky Hidayaturahmah, Putri Amelia Rooswita
Jurnal Epidemiologi Kesehatan Komunitas.2025; 10(3): 126. CrossRef
Comprehensive approaches to diabetes in the elderly: adapting to evolving trends
Jeongmin Lee, Kwang Joon Kim, Yang Sun Park, Yong-ho Lee, Kyeong Hye Park, Hee-Won Jung, Bong-Soo Cha, Hun-Sung Kim, Chang Oh Kim
The Korean Journal of Internal Medicine.2025; 40(6): 1017. CrossRef
Effects of a health coaching program based on Cox’s interaction model in older adults with diabetes mellitus in Korea: a quasi-experimental study
Hye Seung Kang
Journal of Korean Biological Nursing Science.2025; 27(4): 607. CrossRef
Association Between High Blood Folate Levels and Glaucoma in a Representative Korean Population
Ji Young Lee, Jin A. Choi, Sung Pyo Park, Donghyun Jee
Investigative Opthalmology & Visual Science.2024; 65(1): 6. CrossRef
Is the change in longitudinal cognitive function in older adults with diabetes affected by trajectory classes of depressive symptoms?
Gyeong A Kang, Ju Young Yoon
Public Health Nursing.2024; 41(5): 1006. CrossRef
Holistic and Personalized Strategies for Managing in Elderly Type 2 Diabetes Patients
Jae-Seung Yun, Kyuho Kim, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko
Diabetes & Metabolism Journal.2024; 48(4): 531. CrossRef
Association and interaction effect of shift work and the risk for obstructive sleep apnea on diabetes mellitus in middle-aged Korean workers
Kyusung Kim, Hi-Ju Kim, Seunghyun Lee, Wanhyung Lee
Sleep and Breathing.2024; 28(6): 2721. CrossRef
Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
Ja Young Jeon, Dae Jung Kim
Diabetes & Metabolism Journal.2024; 48(5): 837. CrossRef
National trends in type 2 diabetes mellitus stratified by central adiposity using waist-to-height ratio in South Korea, 2005–2022
Hyunjee Kim, Seoyoung Park, Jaeyu Park, Yejun Son, Soeun Kim, Yesol Yim, Hyesu Jo, Kyeongmin Lee, Yi Deun Jeong, Jiyeon Oh, Hanseul Cho, Damiano Pizzol, Jiyoung Hwang, Lee Smith, Dong Keon Yon
Scientific Reports.2024;[Epub] CrossRef
Changes in the Epidemiological Landscape of Diabetes in South Korea: Trends in Prevalence, Incidence, and Healthcare Expenditures
Kyoung Hwa Ha, Dae Jung Kim
Endocrinology and Metabolism.2024; 39(5): 669. CrossRef
Osteoporosis incidence and its associated factors in the older Korean population: findings from a population-based cohort study
Tanmoy Das, Md Abdullah Al Jubayer Biswas, Prosanta Mondal, Sabuj Sarker, Hyun J.“June” Lim
Archives of Osteoporosis.2024;[Epub] CrossRef
Association of Uterine Leiomyoma with Type 2 Diabetes Mellitus in Young Women: A Population-Based Cohort Study
Ji-Hee Sung, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
Diabetes & Metabolism Journal.2024; 48(6): 1105. CrossRef
Socioeconomic inequalities in the prevalence, non-awareness, non-treatment, and non-control of diabetes among South Korean adults in 2021
Seongju Kim, Dong Jun Kim, Hooyeon Lee, Dong Keon Yon
PLOS ONE.2024; 19(11): e0313988. CrossRef
The Growing Challenge of Diabetes Management in an Aging Society
Seung-Hwan Lee
Diabetes & Metabolism Journal.2023; 47(5): 630. CrossRef

Others
Glucose Regulation after Partial Pancreatectomy: A Comparison of Pancreaticoduodenectomy and Distal Pancreatectomy in the Short and Long Term: Jun Suh Lee, Minji Sohn, Kyuho Kim, Yoo-Seok Yoon, Soo Lim; Diabetes Metab J. 2023;47(5):703-714. Published online June 22, 2023; DOI: https://doi.org/10.4093/dmj.2022.0205

9,651 View
302 Download
2 Web of Science
3 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Long term quality of life is becoming increasingly crucial as survival following partial pancreatectomy rises. The purpose of this study was to investigate the difference in glucose dysregulation after pancreaticoduodenectomy (PD) or distal pancreatectomy (DP).
Methods
In this prospective observational study from 2015 to 2018, 224 patients who underwent partial pancreatectomy were selected: 152 (67.9%) received PD and 72 (32.1%) received DP. Comprehensive assessment for glucose regulation, including a 75 g oral glucose tolerance test was conducted preoperatively, and 1, 12, and 52 weeks after surgery. Patients were further monitored up to 3 years to investigate development of new-onset diabetes mellitus (NODM) in patients without diabetes mellitus (DM) at baseline or worsening of glucose regulation (≥1% increase in glycosylated hemoglobin [HbA1c]) in those with preexisting DM.
Results
The disposition index, an integrated measure of β-cell function, decreased 1 week after surgery in both groups, but it increased more than baseline level in the PD group while its decreased level was maintained in the DP group, resulting in a between-group difference at the 1-year examination (P<0.001). During follow-up, the DP group showed higher incidence of NODM and worsening of glucose regulation than the PD group with hazard ratio (HR) 4.29 (95% confidence interval [CI], 1.49 to 12.3) and HR 2.15 (95% CI, 1.09 to 4.24), respectively, in the multivariate analysis including dynamic glycemic excursion profile. In the DP procedure, distal DP and spleen preservation were associated with better glucose regulation. DP had a stronger association with glucose dysregulation than PD.
Conclusion
Proactive surveillance of glucose dysregulation is advised, particularly for patients who receive DP.

Citations

Citations to this article as recorded by

Impaired insulin secretion via the Wnt5a/β-catenin pathway contributes to diabetes development in pancreatic cancer
Minyoung Lee, Ho Seon Park, Hyung Sun Kim, ARim Choi, Ji Hae Nahm, Beom Jin Lim, Jong Suk Park, Chul Woo Ahn, Younhee Ko, Dong Ki Lee, Dong Sup Yoon, Joon Seong Park, Shinae Kang
Experimental & Molecular Medicine.2026; 58(1): 272. CrossRef
Treatment of Pancreatic Neuroendocrine Tumors: Beyond Traditional Surgery and Targeted Therapy
Khyati Bidani, Angela G. Marinovic, Vishali Moond, Prateek Harne, Arkady Broder, Nirav Thosani
Journal of Clinical Medicine.2025; 14(10): 3389. CrossRef
Incidence and risk factors for new-onset diabetes mellitus (NODM) in post-pancreatectomy patients diagnosed with pancreatic adenocarcinoma (PAC): A systematic review
Adavikolanu Kesava Ramgopal, Chandramouli Ramalingam, Kaliyath Soorej Balan, K.S. Abhishek Raghava, Kondapuram Manish, Kari NagaSai Divya, Yadala Ambedkar, Varthya Shobhan Babu, Kondeti Ajay Kumar
Oncoscience.2025; 12: 203. CrossRef

Corrigendum

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins: Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi; Diabetes Metab J. 2022;46(5):817-818. Published online September 19, 2022; DOI: https://doi.org/10.4093/dmj.2022.0295; Corrects: Diabetes Metab J 2022;46(4):517

4,712 View
189 Download
14 Web of Science
12 Crossref

PDF PubReader ePub

Citations

Citations to this article as recorded by

Cholesteryl Ester Transfer Protein Inhibitors: State of the Science
Mojgan Nejabat, Niki Katsiki, Debabrata Mukherjee, Farzin Hadizadeh, Amirhossein Sahebkar
Current Cardiology Reports.2026;[Epub] CrossRef
Statin Therapy and C-reactive Protein in Patients with Kidney Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials
Bahman Razi, Danyal Imani, Saeed Aslani, Zeljko Reiner, Amirhossein Sahebkar
Current Drug Targets.2025; 26(2): 132. CrossRef
Efficacy and safety of evolocumab in statin-treated patients with cardiovascular risk factors: a systematic review and meta-analysis
Mayank Jha, Siddharth Pravin Agrawal, Darshilkumar Maheta, Priyadarshini Bhattacharjee, Hritvik Jain, Jerome Zacks, William H. Frishman, Wilbert S. Aronow
Expert Opinion on Biological Therapy.2025; 25(7): 749. CrossRef
Treatment of dyslipidemia: PCSK-9 in focus
Sandra Singh-Lukač, Ljiljana Popović, Iva Rasulić, Ana Petakov, Jelena Bogdanović, Marija Mitrović, Milica Krstić, Katarina Lalić
Medicinska istrazivanja.2025; 58(3): 197. CrossRef
Innovative Lipid-Lowering Strategies: RNA-Based, Small Molecule, and Protein-Based Therapies
Youngwoo Jang, Eun-Jung Rhee, Sung Hee Choi
Endocrinology and Metabolism.2025; 40(5): 668. CrossRef
Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table
François Mach, Frank L.J. Visseren, Nilo B. Cater, Nejoua Salhi, Jarkko Soronen, Kausik K. Ray, Victoria Delgado, J. Wouter Jukema, Ulrich Laufs, Jose-Luis Zamorano, Emilio Ros, Jogchum Plat, Akos Gabor Gesztes, Lale Tokgozoglu, Chris Packard, Peter Libby
Journal of Clinical Lipidology.2024; 18(5): e685. CrossRef
Engineered exosomes as a prospective therapy for diabetic foot ulcers
Lifei Guo, Dan Xiao, Helin Xing, Guodong Yang, Xuekang Yang
Burns & Trauma.2024;[Epub] CrossRef
Lipidomic profiling in patients with familial hypercholesterolemia: Abnormalities in glycerolipids and oxysterols
Shiva Ganjali, Vladimiro Cardenia, Ambra Bonciolini, Raul D. Santos, Khalid Al-Rasadi, Amirhossein Sahebkar
Clinical Biochemistry.2024; 131-132: 110812. CrossRef
Olezarsen and Plozasiran in Dyslipidemia Management: A Narrative Review of Clinical Trials
Gbolahan Olatunji, Ikponmwosa Jude Ogieuhi, Emmanuel Kokori, Ajekiigbe Victor Oluwatomiwa, Oluwafemi Isaiah Ajimotokan, God-dowell O. Odukudu, Samuel Owolabi, Sopuruchukwu Anyacho, Chijindu Nnaemeka Nwakama, Adetola Emmanuel Babalola, Franklin Andibanbang
High Blood Pressure & Cardiovascular Prevention.2024; 31(6): 567. CrossRef
The Effect of Statin Therapy on Bone Metabolism Markers and Mineral Density: Aa GRADE-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials
Seyyed Mostafa Arabi, Mahla Chambari, Leila Sadat Bahrami, Ali Jafari, Hossein Bahari, Željko Reiner, Amirhossein Sahebkar
Advanced Pharmaceutical Bulletin.2024; 14(3): 591. CrossRef
Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk Factor
Umberto Capece, Shawn Gugliandolo, Cassandra Morciano, Adriana Avolio, Amelia Splendore, Gianfranco Di Giuseppe, Gea Ciccarelli, Laura Soldovieri, Michela Brunetti, Teresa Mezza, Alfredo Pontecorvi, Andrea Giaccari, Francesca Cinti
Nutrients.2024; 16(24): 4318. CrossRef
Remnant Cholesterol, a Valuable Biomarker for Assessing Arteriosclerosis and Cardiovascular Risk: A Systematic Review
Xiang Chen, Li-Hua Li
Cureus.2023;[Epub] CrossRef

Review

Drug/Regimen
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins: Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi; Diabetes Metab J. 2022;46(4):517-532. Published online July 27, 2022; DOI: https://doi.org/10.4093/dmj.2022.0198; Correction in: Diabetes Metab J 2022;46(5):817

27,620 View
1,243 Download
59 Web of Science
62 Crossref

Abstract PDF PubReader ePub

Statins are the cornerstone of the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, even under optimal statin therapy, a significant residual ASCVD risk remains. Therefore, there has been an unmet clinical need for novel lipid-lowering agents that can target low-density lipoprotein cholesterol (LDL-C) and other atherogenic particles. During the past decade, several drugs have been developed for the treatment of dyslipidemia. Inclisiran, a small interfering RNA that targets proprotein convertase subtilisin/kexin type 9 (PCSK9), shows comparable effects to that of PCSK9 monoclonal antibodies. Bempedoic acid, an ATP citrate lyase inhibitor, is a valuable treatment option for the patients with statin intolerance. Pemafibrate, the first selective peroxisome proliferator-activated receptor alpha modulator, showed a favorable benefit-risk balance in phase 2 trial, but the large clinical phase 3 trial (PROMINENT) was recently stopped for futility based on a late interim analysis. High dose icosapent ethyl, a modified eicosapentaenoic acid preparation, shows cardiovascular benefits. Evinacumab, an angiopoietin-like 3 (ANGPTL3) monoclonal antibody, reduces plasma LDL-C levels in patients with refractory hypercholesterolemia. Novel antisense oligonucleotides targeting apolipoprotein C3 (apoC3), ANGPTL3, and lipoprotein(a) have significantly attenuated the levels of their target molecules with beneficial effects on associated dyslipidemias. Apolipoprotein A1 (apoA1) is considered as a potential treatment to exploit the athero-protective effects of high-density lipoprotein cholesterol (HDL-C), but solid clinical evidence is necessary. In this review, we discuss the mode of action and clinical outcomes of these novel lipid-lowering agents beyond statins.

Citations

Citations to this article as recorded by

CURRENT ADVANCES IN LIPOPROTEIN(A) MANAGEMENT: CLINICAL SIGNIFICANCE AND EMERGING THERAPIES
Szymon Zysiak, Rafał Bednarczyk, Natalia Bednarczyk, Agnieszka Kurek, Natalia Krajewska, Aleksandra Lejman, Aleksandra Mazurkiewicz, Hubert Sidor, Monika Wołosik, Radosław Krzysztof Binkowski
International Journal of Innovative Technologies in Social Science.2026;[Epub] CrossRef
Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk in Populations With Different Low‐Density Lipoprotein Cholesterol Elevations: A Prospective Cohort Study
Hong Zheng, Guanlin Chen, Zhenyu Huo, Yulong Lan, Yuxian Wang, Peng Fu, Weiqiang Wu, Haixiang Zheng, Kuangyi Wu, Zegui Huang, Dan Wu, Shouling Wu, Youren Chen
Journal of the American Heart Association.2026;[Epub] CrossRef
The mechanism of perilla oil in regulating lipid metabolism
Jiawei Xia, Yi Wang, Xin Li, Li Liu, Pin Zhang, Wendong Dai, Peng Luo, Guoze Wang, Yanhong Li
Food Chemistry.2025; 476: 143318. CrossRef
The effect of vitamin E supplementation on serum low-density lipoprotein oxidization: A systematic review and meta-analysis of clinical trials
Sepide Amini, Fatemeh Navab, Mohammad Hossein Rouhani, Tannaz Jamialahmadi, Mohammad Bagherniya, Prashant Kesharwani, Amirhossein Sahebkar
European Journal of Pharmacology.2025; 997: 177491. CrossRef
Acromegaly and the risk of cancer: a nationwide population-based cohort study in Korea
Yeo Song Kim, Jae-Seung Yun, Hyunho Kim, Sin Soo Jeun, Bongseong Kim, Sea-Won Lee, Jung Eun Lee, Kyuho Kim, Seung-Hyun Ko, Yu-Bae Ahn, Kyungdo Han, Seung Ho Yang
European Journal of Endocrinology.2025; 192(3): 220. CrossRef
Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?
Katia Azarfar, Boris Decourt, Brandon Sanchez Camacho, John Joshua Lawrence, Tania R. Omondi, Marwan N. Sabbagh
Expert Review of Neurotherapeutics.2025; 25(5): 521. CrossRef
Recent Advances in the Management of Dyslipidemia: A Systematic Review
Huang Jacky Xiao Feng, Yousaf Adil, Moon Julie, Ahmed Ramiz, Uppal Krishma, Sudhakar Pemminati
Cureus.2025;[Epub] CrossRef
Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins
Gala Araujo, Leidy Marian Valencia, Agata Martin-Ozimek, Yosdel Soto, Spencer D. Proctor
Frontiers in Immunology.2025;[Epub] CrossRef
Statins and adhesion molecules: a review of a novel pleiotropic property of statins
Mahvash Sadeghi, Sajad Dehnavi, Sanaz Keshavarz Shahbaz, Khadijeh Koushki, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar
Immunologic Research.2025;[Epub] CrossRef
Discordance of Small Dense LDL Cholesterol Beyond LDL Cholesterol or Non–HDL Cholesterol and Carotid Plaque
Jinqi Wang, Xiaoyu Zhao, Yanchen Zhao, Rui Jin, Yunfei Li, Jiahe Wang, Yueruijing Liu, Zhiyuan Wu, Xiuhua Guo, Lixin Tao
JACC: Asia.2025; 5(8): 1012. CrossRef
Hyperlipidemia and atherosclerosis: experimental models
K. I. Davletova, E. L. Chernolovskaya
Bulletin of Siberian Medicine.2025; 24(2): 141. CrossRef
CORRECTION OF DYSLIPIDEMIA: HISTORICAL ASPECT AND CURRENT VIEW OF THE PROBLEM (REVIEW, PART IІ)
Dmytro D. Diachuk, Galina Z. Moroz, Oleksandr M. Tkalenko
Clinical and Preventive Medicine.2025; (4): 134. CrossRef
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial
Daniel Gaudet, Malgorzata Gonciarz, Xi Shen, Jennifer K. Leohr, Thomas P. Beyer, Jonathan W. Day, Garrett R. Mullins, Eugene Y. Zhen, Maryalice Hartley, Miriam Larouche, Robert J. Konrad, Olivier Benichou, Giacomo Ruotolo
Nature Medicine.2025; 31(8): 2632. CrossRef
Post-transcriptional targeting of PCSK9 by microRNAs: From mechanisms to therapeutic potential
Maryam Mahjoubin-Tehran, Samaneh Rezaei, Tannaz Jamialahmadi, Prashant Kesharwani, Amirhossein Sahebkar
Human Gene.2025; 45: 201456. CrossRef
Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia
Edomias Adyamseged Berhe, Rediet Ambachew Sema, Yididya Mehari Tesfaye, Abel Andargie Berhane, Mikale Dawit, Ephrem Mamo Gebrehiwot, Subah Abderehim Yesuf, Balamurugan Ramatchandirin
Journal of Diabetes Research.2025;[Epub] CrossRef
Dendrobium huoshanense C. Z. Tang & S. J. Cheng alleviates atherosclerosis by reducing lipid and improving vascular endothelial dysfunction
Xiang-Cheng Fan, Wei-You Cao, Min-Yang He, Hui-Kai Wang, Qing Hao, Wen-Jing Liu, Zhao-Ying Ren, Li-Jun Wang, Jing-Yu Wang, Fei-Xue Wang, Lin Jiang, Qiu-Sheng Zheng, Jun Ma, Feng Zhang, Ji-Chun Han, Lei Zheng
Frontiers in Nutrition.2025;[Epub] CrossRef
Two Sides of Triglycerides in Atherogenesis: An Essential Contributor
Anastasia V Poznyak, Sergey Kozlov, Gulalek A Babayeva, Vasily N Sukhorukov, Alexander N Orekhov
Clinical Medicine Insights: Cardiology.2025;[Epub] CrossRef
Time-Restricted Eating, ANGPTL4, and Reduction in Residual Cardiovascular Risk
Alejandro Gugliucci
Journal of Clinical Medicine.2025; 14(19): 7026. CrossRef
Genetic insights into lipid traits and atherosclerosis risk: a Mendelian randomization and polygenic risk score analysis
Hongliang Zhang, Xiaoyu Long, Guannan Niu, Wence Shi, Zhenyan Zhao, Dejing Feng, Hui Sun, Yongjian Wu
International Journal of Surgery.2025; 111(10): 6802. CrossRef
Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: a Comprehensive Review of Mechanisms and Therapeutic Implications
Fatemeh Askarizadeh, Wael Almahmeed, Kasim Sakran Abass, Salim Virani, Amirhossein Sahebkar
Current Atherosclerosis Reports.2025;[Epub] CrossRef
Gut microbiota–cholesterol crosstalk in cardiovascular diseases: mechanisms, metabolites, and therapeutic modulation
Mohammad Abavisani, Seyed Mohammad Sajjadi, Negar Ebadpour, Sercan Karav, Amirhossein Sahebkar
Nutrition & Metabolism.2025;[Epub] CrossRef
Innovations in Diagnosis and Treatment of Coronary Artery Disease
Salaheldin Agamy, Sheref Zaghloul, Zahid Khan, Ahmed Shahin, Ramy Kishk, Ahmed Smman, Luciano Candilio
Diagnostics.2025; 16(1): 98. CrossRef
Clinical Determinants and Prognostic Significance of Circulating Angiopoietin-Like Protein 3 Levels in Patients With Chronic Coronary Syndrome
Hiroki Tanaka, Yunosuke Matsuura, Kinuko Yamamoto, Soichi Komaki, Masashi Yamaguchi, Kohei Moribayashi, Takeshi Ideguchi, Michikazu Nakai, Toshihiro Tsuruda, Koichi Kaikita
Circulation Reports.2025;[Epub] CrossRef
The role of adherence in patients with chronic diseases
Michel Burnier
European Journal of Internal Medicine.2024; 119: 1. CrossRef
Bempedoic acid: new evidence and recommendations on use
Kristina Paponja, Ivan Pećin, Željko Reiner, Maciej Banach
Current Opinion in Lipidology.2024; 35(1): 41. CrossRef
Genetic insights into repurposing statins for hyperthyroidism prevention: a drug-target Mendelian randomization study
Anqi Huang, Xinyi Wu, Jiaqi Lin, Chiju Wei, Wencan Xu
Frontiers in Endocrinology.2024;[Epub] CrossRef
Targeting host-specific metabolic pathways—opportunities and challenges for anti-infective therapy
Monika I. Konaklieva, Balbina J. Plotkin
Frontiers in Molecular Biosciences.2024;[Epub] CrossRef
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?
Petros Adamidis, Despoina Pantazi, Iraklis Moschonas, Evangelos Liberopoulos, Alexandros Tselepis
Journal of Cardiovascular Development and Disease.2024; 11(3): 72. CrossRef
Modulating effects of crocin on lipids and lipoproteins: Mechanisms and potential benefits
Habib Yaribeygi, Mina Maleki, Farin Rashid-Farrokhi, Payman Raise Abdullahi, Mohammad Amin Hemmati, Tannaz Jamialahmadi, Amirhossein Sahebkar
Heliyon.2024; 10(7): e28837. CrossRef
Assessing the Benefits of Lifestyle Influences on Cardiovascu-lar Health After Acute Coronary Syndrome
Marius Rus, Claudia Elena Stanis, Paula Marian, Lilliana Oana Pobirci, Loredana Ioana Banszki, Veronica Huplea, Gheorghe Adrian Osiceanu, Bianca-Maria Pop, Gabriela Dogaru, Felicia Liana Andronie-Cioara
Balneo and PRM Research Journal.2024; 15(Vol.15, no): 660. CrossRef
Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction
Ziyi Sun, Zhangjun Yun, Jianguo Lin, Xiaoning Sun, Qingqing Wang, Jinlong Duan, Cheng Li, Xiaoxiao Zhang, Siyu Xu, Zeqi Wang, Xingjiang Xiong, Kuiwu Yao
Journal of Translational Medicine.2024;[Epub] CrossRef
Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies
Zaheer Qureshi, Mikail Khanzada, Adnan Safi, Eeshal Fatima, Faryal Altaf, Timothy J. Vittorio
Annals of Medicine & Surgery.2024; 86(5): 2818. CrossRef
Therapeutic approach in the treatment of dyslipidemia: Novelties and challenges
Katarina Lalić, Nataša Rajković, Ljiljana Popović, Sandra Singh-Lukač, Iva Rasulić, Ana Petakov, Milica Krstić, Marija Mitrović
Galenika Medical Journal.2024; 3(9): 31. CrossRef
Lipid Variability Induces Endothelial Dysfunction by Increasing Inflammation and Oxidative Stress
Marie Rhee, Joonyub Lee, Eun Young Lee, Kun-Ho Yoon, Seung-Hwan Lee
Endocrinology and Metabolism.2024; 39(3): 511. CrossRef
Exploring the Perceptions and Behaviours of UK Prescribers Concerning Novel Lipid-Lowering Agent Prescriptions: A Qualitative Study
Sarah Baig, Shahrauz Mughal, Yousuf Murad, Mandeep Virdee, Zahraa Jalal
Pharmacy.2024; 12(4): 104. CrossRef
Need of education and training of healthcare professionals on the PCSK9 inhibitors in cardiovascular disease
Jan Schjøtt, Kristine Heitmann
European Journal of Cardiovascular Nursing.2024; 23(8): e191. CrossRef
CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis
Xize Wu, Changbin Yuan, Jiaxiang Pan, Yi Zhou, Xue Pan, Jian Kang, Lihong Ren, Lihong Gong, Yue Li
Scientific Reports.2024;[Epub] CrossRef
Lessons from PROMINENT and prospects for pemafibrate
Jean-Charles Fruchart, Jamila Fruchart-Najib, Shizuya Yamashita, Peter Libby, Koutaro Yokote, Tatsuhiko Kodama, Yohei Tomita, Paul M. Ridker, Michel P. Hermans, Alberto Zambon
Cardiovascular Diabetology.2024;[Epub] CrossRef
A novel lncRNA GM47544 modulates triglyceride metabolism by inducing ubiquitination-dependent protein degradation of APOC3
Qianqian Xiao, Luyun Wang, Jing Wang, Man Wang, Dao Wen Wang, Hu Ding
Molecular Metabolism.2024; 88: 102011. CrossRef
Advances in pharmacotherapy of dyslipidemia
Harshitha Chinta
National Journal of Pharmacology and Therapeutics.2024; 2(2): 68. CrossRef
ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients
Jingfei Chen, Qin Luo, Yanfeng Yi, Jiangang Wang, Pengfei Chen, Fei Luo, Zhenfei Fang
Lipids in Health and Disease.2024;[Epub] CrossRef
Assessing the effects of HMGCR, LPL, and PCSK9 inhibition on sleep apnea: Mendelian randomization analysis of drug targets
Wei Tan, Xiujuan Deng, Xiaoning Tan, Guangbo Tan
Medicine.2024; 103(43): e40194. CrossRef
Causal association between remnant cholesterol level and risk of cardiovascular diseases: a bidirectional two sample mendelian randomization study
Lei Zhong, Bo Xie, Hai-Li Wang, Xiao-Wei Ji
Scientific Reports.2024;[Epub] CrossRef
A bibliometric analysis of immunotherapy for atherosclerosis: trends and hotspots prediction
Jing-Hui Wang, Guan-Rui Pan, Long Jiang
Frontiers in Immunology.2024;[Epub] CrossRef
Liver cancer cells as the model for developing liver-targeted RNAi therapeutics
Beibei Hou, Linhui Qin, Linfeng Huang
Biochemical and Biophysical Research Communications.2023; 644: 85. CrossRef
Insights into Causal Cardiovascular Risk Factors from Mendelian Randomization
C. M. Schooling, J. V. Zhao
Current Cardiology Reports.2023; 25(2): 67. CrossRef
Secoisolariciresinol diglucoside and anethole ameliorate lipid abnormalities, oxidative injury, hypercholesterolemia, heart, and liver conditions
Sana Noreen, Habib‐ur Rehman, Tabussam Tufail, Huma Badar Ul Ain, Chinaza Godswill Awuchi
Food Science & Nutrition.2023; 11(6): 2620. CrossRef
Colesterol remanente, riesgo vascular y prevención de la arteriosclerosis
Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán, Agustín Blanco, Mariano Blasco, José Luís Díaz Díaz, Ángel Díaz Rodríguez, Alipio Mangas, Vicente Pascual, Juan Pedro Botet, Pablo Pérez Martínez
Clínica e Investigación en Arteriosclerosis.2023; 35(4): 206. CrossRef
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
Michael J. Wilkinson, Norman E. Lepor, Erin D. Michos
Journal of the American Heart Association.2023;[Epub] CrossRef
The cell origins of foam cell and lipid metabolism regulated by mechanical stress in atherosclerosis
Zhi Ouyang, Jian Zhong, Junyi Shen, Ye Zeng
Frontiers in Physiology.2023;[Epub] CrossRef
Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
Alejandro Gugliucci
Journal of Clinical Medicine.2023; 12(13): 4399. CrossRef
Remnant cholesterol, vascular risk, and prevention of atherosclerosis
Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán
Clínica e Investigación en Arteriosclerosis (English Edition).2023; 35(4): 206. CrossRef
Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications
Marios Spanakis, Danny Alon-Ellenbogen, Petros Ioannou, Nikolaos Spernovasilis
Pharmacy.2023; 11(4): 130. CrossRef
Advances in Treatment of Dyslipidemia
Jill Dybiec, Wiktoria Baran, Bartłomiej Dąbek, Piotr Fularski, Ewelina Młynarska, Ewa Radzioch, Jacek Rysz, Beata Franczyk
International Journal of Molecular Sciences.2023; 24(17): 13288. CrossRef
Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
Elena Valeria Fuior, Evangelia Zvintzou, Theodosios Filippatos, Katerina Giannatou, Victoria Mparnia, Maya Simionescu, Anca Violeta Gafencu, Kyriakos E. Kypreos
Biomedicines.2023; 11(10): 2696. CrossRef
Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles
Lixin Du, Huiling Lu, Yifei Xiao, Zhihua Guo, Ya Li
Scientific Reports.2023;[Epub] CrossRef
Dysregulation of Cholesterol Homeostasis in Ovarian Cancer
Zahraa Qusairy, Anne Gangloff, Shuk On Annie Leung
Current Oncology.2023; 30(9): 8386. CrossRef
Riesgo residual. Conclusiones
Ángel Cequier, José Luis Zamorano
Revista Española de Cardiología Suplementos.2023; 23: 25. CrossRef
Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study
Zilong Tan, Jing Hong, Aochuan Sun, Mengdi Ding, Jianwu Shen
Frontiers in Endocrinology.2023;[Epub] CrossRef
Bibliometric analysis of residual cardiovascular risk: trends and frontiers
Lin Wang, Sutong Wang, Chaoyuan Song, Yiding Yu, Yuehua Jiang, Yongcheng Wang, Xiao Li
Journal of Health, Population and Nutrition.2023;[Epub] CrossRef
Current Understanding on the Genetic Basis of Key Metabolic Disorders: A Review
Kenneth Francis Rodrigues, Wilson Thau Lym Yong, Md. Safiul Alam Bhuiyan, Shafiquzzaman Siddiquee, Muhammad Dawood Shah, Balu Alagar Venmathi Maran
Biology.2022; 11(9): 1308. CrossRef
Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
Joon Ho Moon, Kyuho Kim, Sung Hee Choi
Endocrinology and Metabolism.2022; 37(4): 575. CrossRef

Original Article

Technology/Device
Glucose Profiles Assessed by Intermittently Scanned Continuous Glucose Monitoring System during the Perioperative Period of Metabolic Surgery: Kyuho Kim, Sung Hee Choi, Hak Chul Jang, Young Suk Park, Tae Jung Oh; Diabetes Metab J. 2022;46(5):713-721. Published online January 24, 2022; DOI: https://doi.org/10.4093/dmj.2021.0164

10,187 View
402 Download
12 Web of Science
14 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Continuous glucose monitoring (CGM) has been widely used in the management of diabetes. However, the usefulness and detailed data during perioperative status were not well studied. In this study, we described the immediate changes of glucose profiles after metabolic surgery using intermittently scanned CGM (isCGM) in individuals with type 2 diabetes mellitus (T2DM).
Methods
This was a prospective, single-center, single-arm study including 20 participants with T2DM. The isCGM (FreeStyle Libre CGM) implantation was performed within 2 weeks before surgery. We compared CGM metrics of 3 days before surgery and 3 days after surgery, and performed the correlation analyses with clinical variables.
Results
The mean glucose significantly decreased after surgery (147.0±40.4 to 95.5±17.1 mg/dL, P<0.001). Time in range (TIR; 70 to 180 mg/dL) did not significantly change after surgery in total. However, it was significantly increased in a subgroup of individuals with glycosylated hemoglobin (HbA1c) ≥8.0%. Time above range (>250 or 180 mg/dL) was significantly decreased in total. In contrast, time below range (<70 or 54 mg/dL) was significantly increased in total and especially in a subgroup of individuals with HbA1c <8.0% after surgery. The coefficient of variation significantly decreased after surgery. Higher baseline HbA1c was correlated with greater improvement in TIR (rho=0.607, P=0.005).
Conclusion
The isCGM identified improvement of mean glucose and glycemic variability, and increase of hypoglycemia after metabolic surgery, but TIR was not significantly changed after surgery. We detected an increase of TIR only in individuals with HbA1c ≥8.0%.

Citations

Citations to this article as recorded by

Impact of Carbohydrate Intake Fluctuations on Glucose Profiles: Insights from Continuous Glucose Monitoring-Based Patient Clustering
Hyun Ah Kim, Kyung Hee Kim, Young Lee, Yoon-Ju Song, Joon Ho Moon, Sung Hee Choi, Tae Jung Oh
Endocrinology and Metabolism.2026; 41(1): 152. CrossRef
Perioperative screening and management of hyperglycemia: a joint position statement from the Brazilian Diabetes Society (SBD), the Brazilian Society of Anesthesiology (SBA) and the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABE
Emerson Cestari Marino, Leandra Anália Freitas Negretto, Rogério Silicani Ribeiro, Denise Momesso, Alina Coutinho Rodrigues Feitosa, Marcos Tadashi Kakitani Toyoshima, Joaquim Custódio da Silva Junior, Sérgio Vencio, Marcio Weissheimer Lauria, João Robert
Diabetology & Metabolic Syndrome.2026;[Epub] CrossRef
Continuous peri-operative glucose monitoring in noncardiac surgery
Alessandro Putzu, Elliot Grange, Raoul Schorer, Eduardo Schiffer, Karim Gariani
European Journal of Anaesthesiology.2025; 42(2): 162. CrossRef
Reality of post-gastrectomy stress hyperglycemia revealed by continuous glucose monitoring: a prospective study
Keiji Nishibeppu, Takeshi Kubota, Yudai Nakabayashi, Hiroyuki Inoue, Kazuya Takabatake, Takuma Ohashi, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Eigo Otsuji
Surgery Today.2025; 55(8): 1181. CrossRef
The usefulness of continuous glucose monitoring in the diagnostic approach to hypoglycemia after metabolic surgery
Diana Cristina Henao, Ana María Gómez, Sofía Robledo, Ricardo Rosero
Mini-invasive Surgery.2025;[Epub] CrossRef
Moving Beyond Glycated Hemoglobin to Glucose Patterns: Newer Indications for Continuous Glucose Monitor Use
Shubham Agarwal, Ron T. Varghese, Renato Savian, Cecilia C. Low Wang, Rodolfo J. Galindo
Endocrine Practice.2025; 31(8): 1046. CrossRef
Predicting hypoglycemia risk after gastrointestinal surgery in type 2 diabetes mellitus: a retrospective cohort study
Huilan Yao, Shijin Yuan, Hongying Pan, Sisi Hong, Chen Huang, Linfang Zhao, Hongdi Yuan, Lei Mei, Yinghong Zheng, Xiaolong Liu, Weina Lu
Frontiers in Endocrinology.2025;[Epub] CrossRef
Nutriomics and artificial intelligence nutrition obesity cohort (NAINOC): a design paper for a prospective cohort for nutrition and obesity research
Minyoung Lee, Sungha Park, Soo-Hyun Park, Ho-Young Park, Yu Ra Lee, Min-Sun Kim, Miso Nam, Jangho Lee, Hyein Seo, Yong-ho Lee, Chan Joo Lee, Jae-Ho Park, Hye Hyun Yoo, Hyun-Jin Kim, Kyong-Oh Shin, Yoshikazu Uchida, Kyungho Park
Clinical Hypertension.2025;[Epub] CrossRef
Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis
Ji Soo Kim, Gyeongsil Lee, Kyung-Il Park, Seung-Won Oh
Diabetes & Metabolism Journal.2024; 48(2): 312. CrossRef
Continuous Glucose Monitoring Captures Glycemic Variability After Roux-en-Y Gastric Bypass in Patients with and Without Type 2 Diabetes Mellitus: A Prospective Cohort Study
Raquel do A. P. Quevedo, Maria Edna de Melo, Cintia Cercato, Ariana E. Fernandes, Anna Carolina B. Dantas, Marco Aurélio Santo, Denis Pajecki, Marcio C. Mancini
Obesity Surgery.2024; 34(8): 2789. CrossRef
Perioperative Management of Adult Patients with Diabetes Wearing Devices: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Expert Consensus Statement
Adriana D. Oprea, Smita K. Kalra, Elizabeth W. Duggan, Linda L. Russell, Richard D. Urman, Basem B. Abdelmalak, Preethi Patel, Kurt J. Pfeifer, Paul J. Grant, Marina M. Charitou, Carlos E. Mendez, Jennifer L. Sherr, Guillermo E. Umpierrez, David C. Klonof
Journal of Clinical Anesthesia.2024; 99: 111627. CrossRef
Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings
Julie L.V. Shaw, Raveendhara R. Bannuru, Lori Beach, Nuha A. ElSayed, Guido Freckmann, Anna K. Füzéry, Angela W.S. Fung, Jeremy Gilbert, Yun Huang, Nichole Korpi-Steiner, Samantha Logan, Rebecca Longo, Dylan MacKay, Lisa Maks, Stefan Pleus, Kendall Rogers
Diabetes Care.2024; 47(12): 2062. CrossRef
Use of Continuous Glucose Monitoring in Patients Following Bariatric Surgery: A Scoping Review
Yang Yu, Susan W. Groth
Obesity Surgery.2023; 33(8): 2573. CrossRef
Asymptomatic Hypoglycemia after Metabolic Surgery: New Insights from Perioperative Continuous Glucose Monitoring
Sang-Man Jin
Diabetes & Metabolism Journal.2022; 46(5): 675. CrossRef

Editorial

Cardiovascular Safety of SGLT2 Inhibitors Compared to DPP4 Inhibitors and Sulfonylureas as the Second-Line of Therapy in T2DM Using Large, Real-World Clinical Data in Korea: Kyuho Kim, Sung Hee Choi; Diabetes Metab J. 2021;45(4):502-504. Published online July 30, 2021; DOI: https://doi.org/10.4093/dmj.2021.0158

7,422 View
215 Download
4 Web of Science
4 Crossref

PDF PubReader ePub

Citations

Citations to this article as recorded by

Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study
Ming Gao, Qiuyu Lin, Kaiyue Hu, Bei Zhong, Tingyi Zhu, Zheng Gong, Kaini Zhang, Xiaoli Chen, Xinyu Chen, Ying Zhang, Yangyang Li, Shaowen Tang, Dongming Su, Xiubin Liang, Yu Liu
Annals of Medicine.2026;[Epub] CrossRef
Comparative risk of cancer associated with SGLT inhibitors and DPP-4 inhibitors in patients with diabetes: a systematic review and meta-analysis
Hamed Hajishah, Parsa Mazloom, Amirhossein Salehi, Danial Kazemi, Reza Samiee, Hossein Majlesi, Mohammad Javad Amini, Arefeh Meyari, Negin Safari Dehnavi, Masood Zangi
Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Development of Transdermal Drug Delivery Approaches to Combat Diabetes: An Update
Priya Singhal, Rupa Mazumder, Anjna Rani, Abhijit Debnath
Current Drug Metabolism.2025; 26(6): 361. CrossRef
The neuroprotective potential of phytochemicals in traumatic brain injury: mechanistic insights and pharmacological implications
Gulam Mustafa Hasan, Saleha Anwar, Anas Shamsi, Sukhwinder Singh Sohal, Md. Imtaiyaz Hassan
Frontiers in Pharmacology.2024;[Epub] CrossRef

Letter

Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide-Cohort Study (Diabetes Metab J 2020;44:737-46): Kyuho Kim, Tae Jung Oh; Diabetes Metab J. 2020;44(6):938-939. Published online December 23, 2020; DOI: https://doi.org/10.4093/dmj.2020.0236

6,174 View
79 Download
1 Crossref

PDF PubReader ePub

Citations

Citations to this article as recorded by

Increased Age of Death and Change in Causes of Death Among Persons With Diabetes Mellitus From the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
SSRN Electronic Journal .2020;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

Search